Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic
Authors:
- Mark D.P. DavisMDMark D.P. Davis
- Katrina M. DyKDKatrina M. Dy
- Steven NelsonSNSteven Nelson
- 1 December 2007
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 57 (6) , 944-956
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Treatment of adult patients with sepsis‐induced coagulopathy and purpura fulminans using a plasma‐derived protein C concentrate (Ceprotin®)Vox Sanguinis, 2006
- Current Management of Purpura Fulminans: A Multicenter StudyJournal of Burn Care & Rehabilitation, 2003
- Clinical trial results with antithrombin III in sepsisCritical Care Medicine, 2000
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- Purpura Fulminans in Pneumococcal Sepsis: Case Report and ReviewScandinavian Journal of Infectious Diseases, 1997
- Postinfectious purpura fulminans caused by an autoantibody directed against protein SThe Journal of Pediatrics, 1995
- Treatment of purpura fulminans in meningococcemia with protein C concentrateThe Journal of Pediatrics, 1995
- Symmetrical peripheral gangrene: association with noradrenaline administrationIntensive Care Medicine, 1992
- Digital gangrene in small cell lung cancer: response to aspirin treatment.Thorax, 1991
- Notes of Uncommon CasesBMJ, 1891